Affimed (Nasdaq: AFMD) is a clinical stage biopharmaceutical company which engineers targeted immunotherapies, seeking to improve patient outcomes through the power of innate immunity. Affimed’s fit-for-purpose ROCK® platform allows innate immune engagers to be designed for specific patient populations. We are developing single and combination therapies to treat cancers.
To strengthen our highly motivated Translational Research and Innovation Team in Heidelberg, Germany, we are looking for a
Reference No: OP2003
The successful candidate will have the unique opportunity to work in a dynamic, highly motivated, multidisciplinary and collegial team.
For any queries please contact Susanne Hering (Tel: +49 (0)6221 6743-675, e-mail: email@example.com).